Author:
Von Lubitz Dag K.J.E,Lin Rick C.-S,Bischofberger Norbert,Beenhakker Mark,Boyd Mellonie,Lipartowska Renata,Jacobson Kenneth A
Reference26 articles.
1. Bischofberger, N., Jacobson, K.A., Von Lubitz, D.K.J.E., 1997. Adenosine A1 receptor agonists as clinically viable agents in treatment of ischemic brain disorders. In: Trembly, B., Slikker, W., Jr. (Eds.), Neuroprotective Agents: Third International Conference, Ann. New York Acad. Sci., Vol. 825, New York, pp. 23–29.
2. Effects of adenosine A3 receptor agonists on astrocytes: induction of cell protection at low and cell death at high concentrations;Ceruti;Drug Dev. Res.,1996
3. Daly, J.W., Jacobson, K.A., 1995. Adenosine receptors: selective agonists and antagonists. In: Belardinelli, L., Pelleg, A. (Eds.), Adenine and Adenosine Nucleotides: From Molecular Biology to Integrative Physiology. Kluwer Academic Publishers, Norwell, pp. 157–166.
4. Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene;De Sarro;Eur. J. Pharmacol.,1996
5. Long-term caffeine treatment leads to decreased susceptibility to NMDA-induced clonic seizures in mice without changes in adenosine A1 receptor number;Georgiev;Brain Res.,1993
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献